Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study

Giorgio Bolis, Giovanna Scarfone, Francesco Raspagliesi, Giorgia Mangili, Saverio Danese, Paolo Scollo, Domenica Lo Russo, Antonella Villa, Paola Daniela Aimone, Giovanni Scambia

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study'. Together they form a unique fingerprint.

Medicine & Life Sciences